Online inquiry

IVTScrip™ mRNA-Human ADAM19, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK8892MR)

This product GTTS-WK8892MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ADAM19 protein. This product can be used in Dendritic cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_033274.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 8728
UniProt ID Q9H013
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ADAM19, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK8892MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK10730MR IVTScrip™ mRNA-Human Additional GABA Compounds, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Additional GABA Compounds
GTTS-WK20338MR IVTScrip™ mRNA-Human ANKS3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKS3
GTTS-WK24156MR IVTScrip™ mRNA-Human ARMC5, (Cap 0, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARMC5
GTTS-WK23878MR IVTScrip™ mRNA-Human ARRDC1-AS1, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARRDC1-AS1
GTTS-WK10766MR IVTScrip™ mRNA-Human ADRA1D, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADRA1D
GTTS-WK24756MR IVTScrip™ mRNA-Human ARMC5, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ARMC5
GTTS-WK26486MR IVTScrip™ mRNA-Human ARHGAP20, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARHGAP20
GTTS-WK19833MR IVTScrip™ mRNA-Human AIM1, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AIM1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW